Proteostasis Therapeutics Overview

Proteostasis Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for PTI.

Quarterly EBIT

-$8.17M

↑ 36.37% YoY

As of Sep 30, 2020

Annual EBIT (TTM)

-$38.78M

↑ 39.56% YoY

Trailing 12 months ending Sep 30, 2020

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin